China SXT Pharmaceuticals Inc
NASDAQ:SXTC
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Price:
2.77
USD
-7.67%
Market Closed
Market Cap:
$506.1m
Income Statement
Earnings Waterfall
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals Inc
Income Statement
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals Inc
Currency: USD
| Dec-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Revenue |
11
N/A
|
7
-34%
|
11
+56%
|
7
-36%
|
6
-10%
|
5
-18%
|
6
+13%
|
5
-18%
|
2
-59%
|
3
+33%
|
3
+7%
|
2
-29%
|
2
-14%
|
2
+13%
|
2
-6%
|
2
-4%
|
2
-12%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(6)
|
(4)
|
(5)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
5
N/A
|
3
-30%
|
6
+79%
|
5
-24%
|
4
-18%
|
3
-28%
|
4
+36%
|
3
-23%
|
0
-88%
|
1
+268%
|
1
-18%
|
0
-58%
|
1
+46%
|
1
-12%
|
0
-28%
|
0
-8%
|
0
-9%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(9)
|
(5)
|
(7)
|
(6)
|
(4)
|
(6)
|
(14)
|
(3)
|
6
|
(2)
|
(9)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(7)
|
(6)
|
(4)
|
(6)
|
(14)
|
(3)
|
6
|
(2)
|
(9)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
3
N/A
|
2
-44%
|
3
+82%
|
2
-40%
|
0
-88%
|
(1)
N/A
|
(6)
-317%
|
(2)
+61%
|
(6)
-184%
|
(5)
+17%
|
(3)
+34%
|
(5)
-52%
|
(14)
-163%
|
(2)
+85%
|
6
N/A
|
(2)
N/A
|
(8)
-401%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
0
|
(0)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(1)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
1
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
3
N/A
|
2
-44%
|
3
+82%
|
2
-40%
|
(2)
N/A
|
(10)
-450%
|
(6)
+38%
|
(3)
+54%
|
(7)
-149%
|
(5)
+26%
|
(4)
+24%
|
(6)
-44%
|
(14)
-138%
|
(3)
+78%
|
6
N/A
|
(3)
N/A
|
(9)
-168%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
(1)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
2
|
1
|
2
|
2
|
(2)
|
(10)
|
(7)
|
(3)
|
(7)
|
(6)
|
(4)
|
(6)
|
(14)
|
(3)
|
6
|
(3)
|
(9)
|
|
| Net Income (Common) |
2
N/A
|
1
-45%
|
2
+84%
|
2
-30%
|
(2)
N/A
|
(10)
-469%
|
(7)
+36%
|
(3)
+58%
|
(7)
-163%
|
(6)
+20%
|
(4)
+28%
|
(6)
-44%
|
(14)
-138%
|
(3)
+78%
|
6
N/A
|
(3)
N/A
|
(9)
-168%
|
|
| EPS (Diluted) |
217
N/A
|
804.05
+271%
|
1 752
+118%
|
1 193.79
-32%
|
-1 274.64
N/A
|
-6 638.7
-421%
|
-1 975.9
+70%
|
-763.88
+61%
|
-1 856.04
-143%
|
-1 103.84
+41%
|
-322.9
+71%
|
-177.7
+45%
|
-225.59
-27%
|
-28.57
+87%
|
14.34
N/A
|
-2.32
N/A
|
-11.46
-394%
|
|
Switch to:
Switch to:
See Also
Discover More
